
|Articles|May 8, 2020
What we expected from the most recent pandemic relief bill
Author(s)Keith A. Reynolds
Advertisement
Anders Gilberg, senior vice president of government affairs for MGMA, speaks April 21 about what was expected in the COVID-19 coronavirus pandemic relief bill that was passed by the U.S. Senate later that day.
Newsletter
Stay informed and empowered with Medical Economics enewsletter, delivering expert insights, financial strategies, practice management tips and technology trends — tailored for today’s physicians.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Medical Economics
1
SleepRes wins FDA clearance for new sleep apnea device
2
Michigan pharmacist sentenced in $6M phantom prescription scheme; new ALS diagnostic blood test; cheese and dementia – Morning Medical Update
3
Why patients with employer-sponsored insurance may struggle to afford it
4
$100M Adderall scheme; Senators warn of emerging nitazene threat; consumers tire of TV drug ads – Morning Medical Update
5








